Aethlon Medical shareholders to own about 95.25% post-merger
Aethlon Medical says pre-merger North Immunology stockholders (including investors participating in the private placement) are expected to own about 95.25% of the combined company.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.